U.S. Senator Tammy Baldwin (D-WI) joined a group of her colleagues in introducing the Capping Prescription Costs Act, ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

On Wednesday, Senator Kristen Gillibrand announced legislation to help reduce prescription drug costs. According to the ...

She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.

Across Indiana, businesses of all sizes work hard to provide quality, affordable health benefits for their employees and their families. But recent efforts — both at the state and federal levels — ...

Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But lawmakers and the second-term governor are at odds over what to do about ...

PBM reform represents a tremendous opportunity. It might be one of the only significant, consequential areas of true ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.

Shares of CVS Health Corp. were having their best day in 26 years on Wednesday, after the drugstore chain and healthcare-services company beat quarterly profit expectations by a wide margin, and as ...

Washington — Senator Kirsten Gillibrand announced new legislation that would, as she says, make prescription drugs more ...